Literature DB >> 33237896

QuickStats: Percentage* of Adults Aged ≥20 Years Who Had Chronic Pain, by Veteran Status and Age Group - National Health Interview Survey, United States, 2019§.

.   

Abstract

Entities:  

Year:  2020        PMID: 33237896      PMCID: PMC7727604          DOI: 10.15585/mmwr.mm6947a6

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
During 2019, military veterans aged ≥20 years were more likely to have chronic pain than were nonveterans (31.5% versus 20.1%). By age group, the likelihood of having chronic pain was higher among veterans than nonveterans for those aged 20–34 years (27.1% versus 9.4%), 35–49 years (27.7% versus 17.7%), and 50–64 years (37.2% versus 26.3%). Among those aged ≥65 years, prevalence of chronic pain did not differ significantly by veteran status (30.8% among veterans versus 31.0% among nonveterans). Among nonveterans, the prevalence of chronic pain increased with age. Among veterans, those aged 50–64 years had the highest prevalence of chronic pain. For more information on this topic, CDC recommends the following link: https://www.cdc.gov/drugoverdose/prescribing/guideline.html.
  2 in total

Review 1.  A Review of Potential National Chronic Pain Surveillance Systems in the United States.

Authors:  Lindsey M Duca; Charles G Helmick; Kamil E Barbour; Richard L Nahin; Michael Von Korff; Louise B Murphy; Kristina Theis; Dana Guglielmo; James Dahlhamer; Linda Porter; Titilola Falasinnu; Sean Mackey
Journal:  J Pain       Date:  2022-04-11       Impact factor: 5.383

2.  Non-pharmacological Treatment for Chronic Pain in US Veterans Treated Within the Veterans Health Administration: Implications for Expansion in US Healthcare Systems.

Authors:  Zachary L Mannes; Malki Stohl; David S Fink; Mark Olfson; Katherine M Keyes; Silvia S Martins; Jaimie L Gradus; Andrew J Saxon; Charles Maynard; Ofir Livne; Sarah Gutkind; Deborah S Hasin
Journal:  J Gen Intern Med       Date:  2022-01-19       Impact factor: 6.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.